NCT06870123 is a NA clinical trial of TT cup and ST-C cup in Osteoarthritis, Hip, sponsored by Limacorporate S.p.a.

Who is sponsoring NCT06870123?

NCT06870123 is sponsored by Limacorporate S.p.a.

What drugs are being tested in NCT06870123?

Interventions in NCT06870123: TT cup and ST-C cup.

What condition does NCT06870123 study?

NCT06870123 studies Osteoarthritis, Hip.

Is NCT06870123 still recruiting?

NCT06870123 is currently active, enrolled. Last updated 11 March 2025.

Last reviewed 2025-03-11 · How we verify

NCT06870123

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Randomized MINIMA Stem with DELTA TT or DELTA ST-C

Active, enrolled NA Last updated 11 March 2025

What this trial tests

NA trial testing TT cup and ST-C cup in Osteoarthritis, Hip in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

15 February 2022

Primary endpoint
15 February 2027

15 February 2029

Quick facts

Lead sponsor	Limacorporate S.p.a
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	120
Start date	15 February 2022
Primary completion	15 February 2027
Estimated completion	15 February 2029
Sites	1 location across Slovakia

Drugs / interventions tested

TT cup and ST-C cup

Conditions studied

Osteoarthritis, Hip — all drugs for Osteoarthritis, Hip →

Sponsor

Limacorporate S.p.a

Who can join

18 and older, any sex, with Osteoarthritis, Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed to provide a clinical and radiographic evaluation of 120 suitable subjects who underwent a total hip arthroplasty with MINIMA stem coupled with Delta TT or Delta ST-C cup.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Hip

Currently open trials in the same condition.

NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
NCT06578182 — The Effect of ColcHicine on the Incidence of Knee or Hip Replacements · Phase 3 · recruiting
NCT06342843 — Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH) · NA · recruiting
NCT06249958 — Transforming Rehabilitation: Personalised Care for a Better Quality of Life · recruiting
NCT05700682 — Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee · recruiting

Other Limacorporate S.p.a trials

Trials by the same sponsor.

NCT05180071 — A Post-market Study Evaluating Clinical and Radiographic Outcomes of Total Elbow Arthroplasty With TEMA · NA · not yet recruiting
NCT05606120 — H-35 CL TRAUMA Cemented Femoral Stem · completed
NCT05007067 — H-29 DELTA Multihole TT Study. · terminated
NCT04884542 — Multigen Plus H Study and AMF TT Cones · recruiting
NCT04594447 — Physica System KR Vs Physica System CR (K-20) · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06870123 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Limacorporate S.p.a
Last refreshed: 11 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06870123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing